Clinical Trials FAQ
Introduction to Clinical Research
Clinical research and clinical trials are fundamental to advancing medical knowledge and improving patient care. These studies are meticulously designed to evaluate the safety, efficacy, and impact of new treatments, medications, medical devices, or healthcare interventions. Clinical research plays a pivotal role in identifying and developing effective therapies that address various medical conditions, ensuring that innovations in healthcare are scientifically validated and tailored to meet the needs of diverse patient populations.
Participation in clinical trials is vital for the continuous progress of medicine, as it helps generate the evidence needed to refine treatment protocols and improve patient outcomes. These studies are conducted following strict ethical standards, ensuring the safety and well-being of participants. Through this rigorous process, clinical research contributes to the evolution of medical practices and the introduction of new, life-changing therapies to the broader healthcare community.
Frequently Asked Questions:
-
Clinical trials, sometimes referred to as clinical research studies, are designed to test new medications, treatments, devices, or interventions before they can be widely used in patients. At Rutgers CRC, clinical trials are essential in evaluating the safety and effectiveness of new treatments or methods for preventing, diagnosing, or treating diseases. These trials play a vital role in advancing medical knowledge and improving patient care. They involve volunteers who meet specific criteria and may have the opportunity to access cutting-edge treatments before they are available to the public.
-
To participate in a clinical trial at Rutgers CRC, you will need to determine if you are eligible based on your medical history and the specific requirements of the trial. You can explore ongoing clinical trials through our website, which lists active studies across various conditions. If a trial interests you, or if your healthcare provider suggests one, you will meet with the clinical research team. During this meeting, they will discuss the study’s goals, procedures, risks, and potential benefits.
-
Rutgers CRC is conducting clinical trials across a range of medical conditions. These include studies on treatments for chronic diseases, such as Multiple Sclerosis, Asthma, Cystic Fibrosis, Scleroderma, and Long COVID, as well as various vaccine trials aimed at improving health outcomes. The goal of these trials is to explore new, effective treatment options and therapies that may not yet be available through standard care.
-
Yes, participant safety is our top priority. All clinical trials at Rutgers CRC follow strict ethical guidelines and protocols. Before participating, you will be asked to sign an Informed Consent form to ensure you understand the trial’s purpose, potential risks, and benefits. Throughout the study, you will be monitored closely by an experienced team of doctors, nurses, and healthcare professionals to ensure your well-being. You also have the right to withdraw from the trial at any time without penalty.
-
Participating in a clinical trial at Rutgers CRC can offer access to innovative treatments and therapies before they are widely available. Additionally, participants receive close monitoring throughout the study. There is no cost to participants for any study-related treatment, care, or testing. Beyond personal benefits, joining a clinical trial helps advance medical research, which may improve healthcare outcomes for future patients.
-
Informed Consent is an essential part of the clinical trial process. Before participating, you will receive detailed information about the study, including the purpose, potential risks, and benefits. You will be asked to sign a consent form, acknowledging that you understand the trial and agree to participate voluntarily. It’s important to know that participation is always voluntary, and you can choose to stop at any time without penalty.
-
All clinical trials at Rutgers CRC are carefully reviewed and monitored to ensure participant safety. The Institutional Review Board (IRB) at Rutgers CRC ensures that each trial meets ethical and safety standards. This oversight group is dedicated to protecting the rights and well-being of all participants, making sure the study is safe and the benefits outweigh any risks.
-
By participating in a clinical trial, you are helping to advance medical research and contribute to the development of new treatments that may benefit others in the future. While there may not always be a direct medical benefit to you, many participants find it rewarding to help researchers gather crucial data that can lead to breakthroughs in healthcare. Additionally, you may receive new treatments or therapies that are not yet widely available.
Phases of Clinical Trials
Phase I
The first stage of testing, usually involving a small group of healthy volunteers. Phase 1 trials focus on determining the safety of a treatment, understanding its side effects, and finding the right dosage.
Phase II
This phase involves a larger group of participants with the condition the treatment is designed to address. Phase 2 trials evaluate the treatment’s effectiveness and continue to monitor its safety.
Phase III
Phase 3 trials involve an even larger group of participants and compare the new treatment to existing treatments or placebos. These trials provide more detailed information on effectiveness, benefits, and potential risks, helping to support regulatory approval for the treatment.
Phase IV
Once a treatment is approved and available on the market, Phase 4 trials continue to monitor its long-term effects and effectiveness in a broader patient population. These trials help ensure that treatments remain safe and effective after public release.